argenx SE
argenx SE ARGNF Peers
See (ARGNF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ARGNF | $586.55 | N/A | 35.8B | 35.72 | $16.42 | N/A |
| NONOF | $73.58 | -0.99% | 326.7B | 20.33 | $3.62 | +2.25% |
| CSLLY | $77.85 | -1.44% | 150.8B | 28.62 | $2.72 | +1.70% |
| CMXHF | $148.56 | N/A | 71.9B | 27.21 | $5.46 | +1.86% |
| UCBJF | $188.94 | +1.42% | 35.9B | 29.99 | $6.30 | +0.85% |
| UCBJY | $90.89 | +2.12% | 34.6B | 28.76 | $3.16 | +0.87% |
| ODTC | $22,005.00 | +29.44% | 24.1B | -0.08 | -$268,995.00 | N/A |
| IVBXF | $9.74 | N/A | 16.1B | -973.95 | -$0.01 | N/A |
| WXIBF | $3.25 | N/A | 13.2B | 29.55 | $0.11 | N/A |
| GNMSF | $211.09 | -0.19% | 13B | 12.38 | $17.05 | N/A |
Stock Comparison
ARGNF vs NONOF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, NONOF has a market cap of 326.7B. Regarding current trading prices, ARGNF is priced at $586.55, while NONOF trades at $73.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas NONOF's P/E ratio is 20.33. In terms of profitability, ARGNF's ROE is +0.16%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, ARGNF is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CSLLY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, CSLLY has a market cap of 150.8B. Regarding current trading prices, ARGNF is priced at $586.55, while CSLLY trades at $77.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas CSLLY's P/E ratio is 28.62. In terms of profitability, ARGNF's ROE is +0.16%, compared to CSLLY's ROE of +0.26%. Regarding short-term risk, ARGNF is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CMXHF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, CMXHF has a market cap of 71.9B. Regarding current trading prices, ARGNF is priced at $586.55, while CMXHF trades at $148.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas CMXHF's P/E ratio is 27.21. In terms of profitability, ARGNF's ROE is +0.16%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, ARGNF is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs UCBJF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, UCBJF has a market cap of 35.9B. Regarding current trading prices, ARGNF is priced at $586.55, while UCBJF trades at $188.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas UCBJF's P/E ratio is 29.99. In terms of profitability, ARGNF's ROE is +0.16%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, ARGNF is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs UCBJY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, UCBJY has a market cap of 34.6B. Regarding current trading prices, ARGNF is priced at $586.55, while UCBJY trades at $90.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas UCBJY's P/E ratio is 28.76. In terms of profitability, ARGNF's ROE is +0.16%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, ARGNF is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs ODTC Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, ARGNF is priced at $586.55, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas ODTC's P/E ratio is -0.08. In terms of profitability, ARGNF's ROE is +0.16%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, ARGNF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs IVBXF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, IVBXF has a market cap of 16.1B. Regarding current trading prices, ARGNF is priced at $586.55, while IVBXF trades at $9.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas IVBXF's P/E ratio is -973.95. In terms of profitability, ARGNF's ROE is +0.16%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, ARGNF is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs WXIBF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, WXIBF has a market cap of 13.2B. Regarding current trading prices, ARGNF is priced at $586.55, while WXIBF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas WXIBF's P/E ratio is 29.55. In terms of profitability, ARGNF's ROE is +0.16%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, ARGNF is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs GNMSF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, GNMSF has a market cap of 13B. Regarding current trading prices, ARGNF is priced at $586.55, while GNMSF trades at $211.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas GNMSF's P/E ratio is 12.38. In terms of profitability, ARGNF's ROE is +0.16%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, ARGNF is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs WXXWY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, WXXWY has a market cap of 12.7B. Regarding current trading prices, ARGNF is priced at $586.55, while WXXWY trades at $6.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas WXXWY's P/E ratio is 27.47. In terms of profitability, ARGNF's ROE is +0.16%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, ARGNF is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs SBMFF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, SBMFF has a market cap of 11.4B. Regarding current trading prices, ARGNF is priced at $586.55, while SBMFF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas SBMFF's P/E ratio is 31.86. In terms of profitability, ARGNF's ROE is +0.16%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, ARGNF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs SBHMY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, SBHMY has a market cap of 8.5B. Regarding current trading prices, ARGNF is priced at $586.55, while SBHMY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, ARGNF's ROE is +0.16%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, ARGNF is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs TRSBF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, TRSBF has a market cap of 7B. Regarding current trading prices, ARGNF is priced at $586.55, while TRSBF trades at $2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas TRSBF's P/E ratio is 24.58. In terms of profitability, ARGNF's ROE is +0.16%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, ARGNF is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs AKBLF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, AKBLF has a market cap of 6.2B. Regarding current trading prices, ARGNF is priced at $586.55, while AKBLF trades at $27.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas AKBLF's P/E ratio is 42.54. In terms of profitability, ARGNF's ROE is +0.16%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, ARGNF is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs TLPPF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, TLPPF has a market cap of 5.5B. Regarding current trading prices, ARGNF is priced at $586.55, while TLPPF trades at $16.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas TLPPF's P/E ratio is 181.94. In terms of profitability, ARGNF's ROE is +0.16%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, ARGNF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs ABCZF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, ARGNF is priced at $586.55, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, ARGNF's ROE is +0.16%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, ARGNF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs INCPF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, ARGNF is priced at $586.55, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas INCPF's P/E ratio is -108.67. In terms of profitability, ARGNF's ROE is +0.16%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, ARGNF is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs GNNSF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, GNNSF has a market cap of 4.7B. Regarding current trading prices, ARGNF is priced at $586.55, while GNNSF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas GNNSF's P/E ratio is -27.50. In terms of profitability, ARGNF's ROE is +0.16%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, ARGNF is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs LABFF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, ARGNF is priced at $586.55, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas LABFF's P/E ratio is 28.95. In terms of profitability, ARGNF's ROE is +0.16%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, ARGNF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs ZLDPF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, ZLDPF has a market cap of 4.1B. Regarding current trading prices, ARGNF is priced at $586.55, while ZLDPF trades at $57.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas ZLDPF's P/E ratio is -21.35. In terms of profitability, ARGNF's ROE is +0.16%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, ARGNF is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CAMRF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, CAMRF has a market cap of 3.7B. Regarding current trading prices, ARGNF is priced at $586.55, while CAMRF trades at $63.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas CAMRF's P/E ratio is 64.95. In terms of profitability, ARGNF's ROE is +0.16%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, ARGNF is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs REGMF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, REGMF has a market cap of 3.4B. Regarding current trading prices, ARGNF is priced at $586.55, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas REGMF's P/E ratio is -13.32. In terms of profitability, ARGNF's ROE is +0.16%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, ARGNF is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs TKBIF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, ARGNF is priced at $586.55, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, ARGNF's ROE is +0.16%, compared to TKBIF's ROE of N/A. Regarding short-term risk, ARGNF is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs MPSYF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, ARGNF is priced at $586.55, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, ARGNF's ROE is +0.16%, compared to MPSYF's ROE of +2.51%. Regarding short-term risk, ARGNF is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs SHJBF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, SHJBF has a market cap of 2.8B. Regarding current trading prices, ARGNF is priced at $586.55, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas SHJBF's P/E ratio is -10.94. In terms of profitability, ARGNF's ROE is +0.16%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, ARGNF is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs BVNKF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, BVNKF has a market cap of 2.1B. Regarding current trading prices, ARGNF is priced at $586.55, while BVNKF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas BVNKF's P/E ratio is 10.62. In terms of profitability, ARGNF's ROE is +0.16%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, ARGNF is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs BVNRY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, BVNRY has a market cap of 2.1B. Regarding current trading prices, ARGNF is priced at $586.55, while BVNRY trades at $8.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas BVNRY's P/E ratio is 10.38. In terms of profitability, ARGNF's ROE is +0.16%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, ARGNF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs ASPHF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, ASPHF has a market cap of 2B. Regarding current trading prices, ARGNF is priced at $586.55, while ASPHF trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas ASPHF's P/E ratio is -32.36. In terms of profitability, ARGNF's ROE is +0.16%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, ARGNF is less volatile compared to ASPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs BTTAY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, ARGNF is priced at $586.55, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, ARGNF's ROE is +0.16%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, ARGNF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs GLPGF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, GLPGF has a market cap of 1.8B. Regarding current trading prices, ARGNF is priced at $586.55, while GLPGF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas GLPGF's P/E ratio is -8.76. In terms of profitability, ARGNF's ROE is +0.16%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, ARGNF is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs BRCTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, ARGNF is priced at $586.55, while BRCTF trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas BRCTF's P/E ratio is 18.25. In terms of profitability, ARGNF's ROE is +0.16%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, ARGNF is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs GENSF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, GENSF has a market cap of 1.7B. Regarding current trading prices, ARGNF is priced at $586.55, while GENSF trades at $26.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas GENSF's P/E ratio is -325.12. In terms of profitability, ARGNF's ROE is +0.16%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, ARGNF is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs PHMMF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, PHMMF has a market cap of 1.6B. Regarding current trading prices, ARGNF is priced at $586.55, while PHMMF trades at $93.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas PHMMF's P/E ratio is 71.61. In terms of profitability, ARGNF's ROE is +0.16%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, ARGNF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs ONTTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, ONTTF has a market cap of 1.6B. Regarding current trading prices, ARGNF is priced at $586.55, while ONTTF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas ONTTF's P/E ratio is -7.64. In terms of profitability, ARGNF's ROE is +0.16%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, ARGNF is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs BIESF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, ARGNF is priced at $586.55, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas BIESF's P/E ratio is -44.44. In terms of profitability, ARGNF's ROE is +0.16%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, ARGNF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs PPTDF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, PPTDF has a market cap of 1.4B. Regarding current trading prices, ARGNF is priced at $586.55, while PPTDF trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas PPTDF's P/E ratio is 14.05. In terms of profitability, ARGNF's ROE is +0.16%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, ARGNF is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CSBTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, CSBTF has a market cap of 1.3B. Regarding current trading prices, ARGNF is priced at $586.55, while CSBTF trades at $33.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas CSBTF's P/E ratio is -276.83. In terms of profitability, ARGNF's ROE is +0.16%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, ARGNF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs MEOBF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, MEOBF has a market cap of 1.2B. Regarding current trading prices, ARGNF is priced at $586.55, while MEOBF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas MEOBF's P/E ratio is -10.72. In terms of profitability, ARGNF's ROE is +0.16%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, ARGNF is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs NURPF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, ARGNF is priced at $586.55, while NURPF trades at $8.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas NURPF's P/E ratio is 12.41. In terms of profitability, ARGNF's ROE is +0.16%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, ARGNF is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs SNBIF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, SNBIF has a market cap of 1B. Regarding current trading prices, ARGNF is priced at $586.55, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, ARGNF's ROE is +0.16%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, ARGNF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs HBMHF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, HBMHF has a market cap of 931.2M. Regarding current trading prices, ARGNF is priced at $586.55, while HBMHF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas HBMHF's P/E ratio is 36.67. In terms of profitability, ARGNF's ROE is +0.16%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, ARGNF is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs ASCLF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, ASCLF has a market cap of 904M. Regarding current trading prices, ARGNF is priced at $586.55, while ASCLF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas ASCLF's P/E ratio is -23.31. In terms of profitability, ARGNF's ROE is +0.16%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, ARGNF is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs PHGUF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, PHGUF has a market cap of 782.4M. Regarding current trading prices, ARGNF is priced at $586.55, while PHGUF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas PHGUF's P/E ratio is -57.50. In terms of profitability, ARGNF's ROE is +0.16%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, ARGNF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs BPMUF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, BPMUF has a market cap of 708.1M. Regarding current trading prices, ARGNF is priced at $586.55, while BPMUF trades at $57.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas BPMUF's P/E ratio is 8.14. In terms of profitability, ARGNF's ROE is +0.16%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, ARGNF is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CSPHF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, CSPHF has a market cap of 703M. Regarding current trading prices, ARGNF is priced at $586.55, while CSPHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas CSPHF's P/E ratio is -51.80. In terms of profitability, ARGNF's ROE is +0.16%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, ARGNF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs SOLTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, SOLTF has a market cap of 632.7M. Regarding current trading prices, ARGNF is priced at $586.55, while SOLTF trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas SOLTF's P/E ratio is -38.89. In terms of profitability, ARGNF's ROE is +0.16%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, ARGNF is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs BXPHF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, BXPHF has a market cap of 568.7M. Regarding current trading prices, ARGNF is priced at $586.55, while BXPHF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas BXPHF's P/E ratio is -29.00. In terms of profitability, ARGNF's ROE is +0.16%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, ARGNF is more volatile compared to BXPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs INRLF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, INRLF has a market cap of 527.2M. Regarding current trading prices, ARGNF is priced at $586.55, while INRLF trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas INRLF's P/E ratio is -4.84. In terms of profitability, ARGNF's ROE is +0.16%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, ARGNF is less volatile compared to INRLF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs IDRSF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, IDRSF has a market cap of 505.8M. Regarding current trading prices, ARGNF is priced at $586.55, while IDRSF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas IDRSF's P/E ratio is -1.36. In terms of profitability, ARGNF's ROE is +0.16%, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, ARGNF is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CLTEF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, CLTEF has a market cap of 504.7M. Regarding current trading prices, ARGNF is priced at $586.55, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, ARGNF's ROE is +0.16%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, ARGNF is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs VBIZF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, VBIZF has a market cap of 503.4M. Regarding current trading prices, ARGNF is priced at $586.55, while VBIZF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas VBIZF's P/E ratio is 24.20. In terms of profitability, ARGNF's ROE is +0.16%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, ARGNF is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CKDXF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, CKDXF has a market cap of 478.2M. Regarding current trading prices, ARGNF is priced at $586.55, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, ARGNF's ROE is +0.16%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, ARGNF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs AAVXF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, AAVXF has a market cap of 461.9M. Regarding current trading prices, ARGNF is priced at $586.55, while AAVXF trades at $7.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas AAVXF's P/E ratio is -2.13. In terms of profitability, ARGNF's ROE is +0.16%, compared to AAVXF's ROE of -2.11%. Regarding short-term risk, ARGNF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs TBGNF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, ARGNF is priced at $586.55, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, ARGNF's ROE is +0.16%, compared to TBGNF's ROE of N/A. Regarding short-term risk, ARGNF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs PTCHF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, PTCHF has a market cap of 420.3M. Regarding current trading prices, ARGNF is priced at $586.55, while PTCHF trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas PTCHF's P/E ratio is 8.33. In terms of profitability, ARGNF's ROE is +0.16%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, ARGNF is less volatile compared to PTCHF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs NWBO Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, NWBO has a market cap of 378.4M. Regarding current trading prices, ARGNF is priced at $586.55, while NWBO trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas NWBO's P/E ratio is -4.37. In terms of profitability, ARGNF's ROE is +0.16%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, ARGNF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CYDY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, CYDY has a market cap of 377.4M. Regarding current trading prices, ARGNF is priced at $586.55, while CYDY trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas CYDY's P/E ratio is -15.31. In terms of profitability, ARGNF's ROE is +0.16%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, ARGNF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CLVLF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, CLVLF has a market cap of 361.9M. Regarding current trading prices, ARGNF is priced at $586.55, while CLVLF trades at $7.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas CLVLF's P/E ratio is 14.44. In terms of profitability, ARGNF's ROE is +0.16%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, ARGNF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs HLOSF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, HLOSF has a market cap of 321.6M. Regarding current trading prices, ARGNF is priced at $586.55, while HLOSF trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas HLOSF's P/E ratio is -10.23. In terms of profitability, ARGNF's ROE is +0.16%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, ARGNF is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs IVEVF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, IVEVF has a market cap of 317.2M. Regarding current trading prices, ARGNF is priced at $586.55, while IVEVF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas IVEVF's P/E ratio is -0.66. In terms of profitability, ARGNF's ROE is +0.16%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, ARGNF is less volatile compared to IVEVF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CLVLY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, CLVLY has a market cap of 315.8M. Regarding current trading prices, ARGNF is priced at $586.55, while CLVLY trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas CLVLY's P/E ratio is 12.60. In terms of profitability, ARGNF's ROE is +0.16%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, ARGNF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs PBBIF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, ARGNF is priced at $586.55, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, ARGNF's ROE is +0.16%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, ARGNF is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs PRRUF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, PRRUF has a market cap of 277.5M. Regarding current trading prices, ARGNF is priced at $586.55, while PRRUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas PRRUF's P/E ratio is -9.50. In terms of profitability, ARGNF's ROE is +0.16%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, ARGNF is less volatile compared to PRRUF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs ORYZF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, ORYZF has a market cap of 249.8M. Regarding current trading prices, ARGNF is priced at $586.55, while ORYZF trades at $3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas ORYZF's P/E ratio is -46.05. In terms of profitability, ARGNF's ROE is +0.16%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, ARGNF is less volatile compared to ORYZF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs NWPHF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, ARGNF is priced at $586.55, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas NWPHF's P/E ratio is N/A. In terms of profitability, ARGNF's ROE is +0.16%, compared to NWPHF's ROE of N/A. Regarding short-term risk, ARGNF is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs MDCLF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, MDCLF has a market cap of 230.7M. Regarding current trading prices, ARGNF is priced at $586.55, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, ARGNF's ROE is +0.16%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, ARGNF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs BSEM Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, BSEM has a market cap of 222.7M. Regarding current trading prices, ARGNF is priced at $586.55, while BSEM trades at $13.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas BSEM's P/E ratio is -23.91. In terms of profitability, ARGNF's ROE is +0.16%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, ARGNF is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs BOVNF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, ARGNF is priced at $586.55, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas BOVNF's P/E ratio is -5.98. In terms of profitability, ARGNF's ROE is +0.16%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, ARGNF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs SLNCF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, SLNCF has a market cap of 212.5M. Regarding current trading prices, ARGNF is priced at $586.55, while SLNCF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas SLNCF's P/E ratio is -2.94. In terms of profitability, ARGNF's ROE is +0.16%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, ARGNF is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs RAONF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, RAONF has a market cap of 212M. Regarding current trading prices, ARGNF is priced at $586.55, while RAONF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas RAONF's P/E ratio is -20.33. In terms of profitability, ARGNF's ROE is +0.16%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, ARGNF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs FPHAF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, ARGNF is priced at $586.55, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, ARGNF's ROE is +0.16%, compared to FPHAF's ROE of N/A. Regarding short-term risk, ARGNF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs VSBC Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, ARGNF is priced at $586.55, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas VSBC's P/E ratio is N/A. In terms of profitability, ARGNF's ROE is +0.16%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, ARGNF is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs FGHQF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, ARGNF is priced at $586.55, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, ARGNF's ROE is +0.16%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, ARGNF is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs HNSBF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, HNSBF has a market cap of 203.4M. Regarding current trading prices, ARGNF is priced at $586.55, while HNSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, ARGNF's ROE is +0.16%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, ARGNF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs NGENF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, NGENF has a market cap of 203.4M. Regarding current trading prices, ARGNF is priced at $586.55, while NGENF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas NGENF's P/E ratio is -10.00. In terms of profitability, ARGNF's ROE is +0.16%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, ARGNF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs BRIBF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, BRIBF has a market cap of 190.3M. Regarding current trading prices, ARGNF is priced at $586.55, while BRIBF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas BRIBF's P/E ratio is -2.60. In terms of profitability, ARGNF's ROE is +0.16%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, ARGNF is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs SPHDF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, SPHDF has a market cap of 190M. Regarding current trading prices, ARGNF is priced at $586.55, while SPHDF trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas SPHDF's P/E ratio is -3.27. In terms of profitability, ARGNF's ROE is +0.16%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, ARGNF is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs GNFTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, GNFTF has a market cap of 176.3M. Regarding current trading prices, ARGNF is priced at $586.55, while GNFTF trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, ARGNF's ROE is +0.16%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, ARGNF is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs ADOCY Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, ARGNF is priced at $586.55, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, ARGNF's ROE is +0.16%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, ARGNF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs OPORF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, OPORF has a market cap of 164.9M. Regarding current trading prices, ARGNF is priced at $586.55, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas OPORF's P/E ratio is 12.00. In terms of profitability, ARGNF's ROE is +0.16%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, ARGNF is less volatile compared to OPORF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs IPHYF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, IPHYF has a market cap of 159.9M. Regarding current trading prices, ARGNF is priced at $586.55, while IPHYF trades at $1.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas IPHYF's P/E ratio is -2.48. In terms of profitability, ARGNF's ROE is +0.16%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, ARGNF is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs MLLCF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, ARGNF is priced at $586.55, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas MLLCF's P/E ratio is -2.02. In terms of profitability, ARGNF's ROE is +0.16%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, ARGNF is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs AVCTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, AVCTF has a market cap of 155.1M. Regarding current trading prices, ARGNF is priced at $586.55, while AVCTF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas AVCTF's P/E ratio is -3.34. In terms of profitability, ARGNF's ROE is +0.16%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, ARGNF is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs RECEF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, RECEF has a market cap of 144.2M. Regarding current trading prices, ARGNF is priced at $586.55, while RECEF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas RECEF's P/E ratio is -8.33. In terms of profitability, ARGNF's ROE is +0.16%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, ARGNF is more volatile compared to RECEF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs AAPGV Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, ARGNF is priced at $586.55, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas AAPGV's P/E ratio is N/A. In terms of profitability, ARGNF's ROE is +0.16%, compared to AAPGV's ROE of N/A. Regarding short-term risk, ARGNF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs AMGXF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, AMGXF has a market cap of 126.7M. Regarding current trading prices, ARGNF is priced at $586.55, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, ARGNF's ROE is +0.16%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, ARGNF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs SCNLF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, SCNLF has a market cap of 123.4M. Regarding current trading prices, ARGNF is priced at $586.55, while SCNLF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas SCNLF's P/E ratio is -3.97. In terms of profitability, ARGNF's ROE is +0.16%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, ARGNF is less volatile compared to SCNLF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs PSTTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, ARGNF is priced at $586.55, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, ARGNF's ROE is +0.16%, compared to PSTTF's ROE of N/A. Regarding short-term risk, ARGNF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs EPRXF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, ARGNF is priced at $586.55, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, ARGNF's ROE is +0.16%, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, ARGNF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs BRAXF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, BRAXF has a market cap of 104.1M. Regarding current trading prices, ARGNF is priced at $586.55, while BRAXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas BRAXF's P/E ratio is N/A. In terms of profitability, ARGNF's ROE is +0.16%, compared to BRAXF's ROE of -2.49%. Regarding short-term risk, ARGNF is more volatile compared to BRAXF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs ADOIF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, ARGNF is priced at $586.55, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, ARGNF's ROE is +0.16%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, ARGNF is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs JWCTF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, JWCTF has a market cap of 101.3M. Regarding current trading prices, ARGNF is priced at $586.55, while JWCTF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas JWCTF's P/E ratio is -1.25. In terms of profitability, ARGNF's ROE is +0.16%, compared to JWCTF's ROE of -0.47%. Regarding short-term risk, ARGNF is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs PBIGF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, PBIGF has a market cap of 100M. Regarding current trading prices, ARGNF is priced at $586.55, while PBIGF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas PBIGF's P/E ratio is -8.56. In terms of profitability, ARGNF's ROE is +0.16%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, ARGNF is less volatile compared to PBIGF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs TRGNF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, TRGNF has a market cap of 92.4M. Regarding current trading prices, ARGNF is priced at $586.55, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas TRGNF's P/E ratio is -2.12. In terms of profitability, ARGNF's ROE is +0.16%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, ARGNF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs CMVLF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, CMVLF has a market cap of 90.1M. Regarding current trading prices, ARGNF is priced at $586.55, while CMVLF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas CMVLF's P/E ratio is -1.87. In terms of profitability, ARGNF's ROE is +0.16%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, ARGNF is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs IUGNF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, IUGNF has a market cap of 89.6M. Regarding current trading prices, ARGNF is priced at $586.55, while IUGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas IUGNF's P/E ratio is -1.20. In terms of profitability, ARGNF's ROE is +0.16%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, ARGNF is more volatile compared to IUGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs MCURF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, ARGNF is priced at $586.55, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas MCURF's P/E ratio is -16.90. In terms of profitability, ARGNF's ROE is +0.16%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, ARGNF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs ACHFF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, ACHFF has a market cap of 83.7M. Regarding current trading prices, ARGNF is priced at $586.55, while ACHFF trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas ACHFF's P/E ratio is -31.75. In terms of profitability, ARGNF's ROE is +0.16%, compared to ACHFF's ROE of +0.53%. Regarding short-term risk, ARGNF is more volatile compared to ACHFF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.
ARGNF vs KNTPF Comparison
ARGNF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGNF stands at 35.8B. In comparison, KNTPF has a market cap of 77M. Regarding current trading prices, ARGNF is priced at $586.55, while KNTPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGNF currently has a P/E ratio of 35.72, whereas KNTPF's P/E ratio is -3.55. In terms of profitability, ARGNF's ROE is +0.16%, compared to KNTPF's ROE of -4.62%. Regarding short-term risk, ARGNF is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for ARGNF.